# Subcutaneous Talquetamab in Elderly Patients With Multiple Myeloma in Early Relapse

> **NCT06827860** · PHASE2 · RECRUITING · sponsor: **Larysa Sanchez** · enrollment: 23 (estimated)

## Conditions studied

- Multiple Myeloma in Relapse

## Interventions

- **DRUG:** Talquetamab
- **DRUG:** Daratumumab

## Key facts

- **NCT ID:** NCT06827860
- **Lead sponsor:** Larysa Sanchez
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-11-18
- **Primary completion:** 2027-01
- **Final completion:** 2028-01
- **Target enrollment:** 23 (ESTIMATED)
- **Last updated:** 2025-12-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06827860

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06827860, "Subcutaneous Talquetamab in Elderly Patients With Multiple Myeloma in Early Relapse". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT06827860. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*